# ClinicalTrials.gov record NCT00002864

> PeptideScanner retained ClinicalTrials.gov record NCT00002864 at 2026-07-30T20:29:13.581Z. Its registry update date was 2020-04-01, and PeptideScanner's reviewed identity mapping was octreotide.

- Evidence object: `story:clinicaltrials-gov-nct00002864-octreotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2020-04-01
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00002864-octreotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00002864-octreotide-v1.json
- Content SHA-256: `9010a87b7abb457e5843e6f8352e0fd4789e3169799525ee844a0a82d508bc63`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00002864 ([`ctg-observation-nct00002864-2020-04-01-8c17ee9695be`](#source-ctg-observation-nct00002864-2020-04-01-8c17ee9695be))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00002864 at 2026-07-30T20:29:13.581Z. Its registry update date was 2020-04-01, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct00002864-2020-04-01-8c17ee9695be`](#source-ctg-observation-nct00002864-2020-04-01-8c17ee9695be))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00002864 at 2026-07-30T20:29:13.581Z. Its registry update date was 2020-04-01, and PeptideScanner's reviewed identity mapping was octreotide. ([`ctg-observation-nct00002864-2020-04-01-8c17ee9695be`](#source-ctg-observation-nct00002864-2020-04-01-8c17ee9695be))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00002864-2020-04-01-8c17ee9695be`](#source-ctg-observation-nct00002864-2020-04-01-8c17ee9695be))

## Sources

<a id="source-ctg-observation-nct00002864-2020-04-01-8c17ee9695be"></a>
- **ClinicalTrials.gov record NCT00002864 · retained source version 2020-04-01:8c17ee9695be9abed88361f6a5a757c76d9806e0e97f59949158e1b9093308b0** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00002864) (`ctg-observation-nct00002864-2020-04-01-8c17ee9695be`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00002864." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00002864-octreotide-v1.json SHA-256: 9010a87b7abb457e5843e6f8352e0fd4789e3169799525ee844a0a82d508bc63.